Your browser is no longer supported. Please, upgrade your browser.
Settings
ARNA Arena Pharmaceuticals, Inc. daily Stock Chart
ARNA [NASD]
Arena Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.72 Insider Own0.10% Shs Outstand49.37M Perf Week-0.42%
Market Cap2.00B Forward P/E- EPS next Y-3.34 Insider Trans-37.01% Shs Float49.33M Perf Month7.85%
Income-114.10M PEG- EPS next Q-0.79 Inst Own84.10% Short Float6.41% Perf Quarter1.27%
Sales9.60M P/S208.53 EPS this Y-484.40% Inst Trans-0.33% Short Ratio4.92 Perf Half Y-16.12%
Book/sh10.76 P/B3.77 EPS next Y- ROA-19.70% Target Price62.78 Perf Year31.87%
Cash/sh11.38 P/C3.56 EPS next 5Y- ROE-23.80% 52W Range29.52 - 50.05 Perf YTD19.37%
Dividend- P/FCF- EPS past 5Y8.60% ROI-34.20% 52W High-18.98% Beta1.77
Dividend %- Quick Ratio- Sales past 5Y-5.00% Gross Margin- 52W Low37.36% ATR2.20
Employees159 Current Ratio26.10 Sales Q/Q50.00% Oper. Margin- RSI (14)53.55 Volatility4.43% 5.44%
OptionableYes Debt/Eq0.11 EPS Q/Q24.90% Profit Margin- Rel Volume0.89 Prev Close40.19
ShortableYes LT Debt/Eq0.10 EarningsNov 07 AMC Payout- Avg Volume642.30K Price40.55
Recom1.80 SMA204.16% SMA502.46% SMA200-0.87% Volume571,170 Change0.90%
May-31-18Initiated RBC Capital Mkts Outperform $65
Mar-21-18Upgrade Needham Hold → Buy $60
Mar-20-18Reiterated JMP Securities Mkt Outperform $63 → $79
Jan-18-18Resumed Credit Suisse Outperform $44
Jan-18-18Initiated Credit Suisse Outperform $44
Jan-03-18Upgrade Wells Fargo Market Perform → Outperform
Jul-11-17Reiterated Citigroup Buy $23 → $37
Jul-07-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Jun-27-17Initiated Citigroup Buy $23
May-19-17Initiated Leerink Partners Outperform $5
Sep-15-16Initiated FBR & Co. Outperform $6
Mar-01-16Reiterated RBC Capital Mkts Sector Perform $2 → $1.50
Nov-11-15Reiterated RBC Capital Mkts Sector Perform $5 → $2
Oct-28-15Reiterated WallachBeth Buy $6 → $4
May-12-15Reiterated WallachBeth Buy $8 → $6
Jan-23-15Initiated RBC Capital Mkts Sector Perform $5
Aug-07-14Reiterated WallachBeth Buy $9 → $8
Nov-15-13Initiated WallachBeth Buy $9
Oct-03-13Initiated Cowen Market Perform $4.50
Oct-25-10Reiterated Barclays Capital Underweight $3 → $2
Dec-06-18 06:50AM  Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and Sarepta Therapeutics ACCESSWIRE
Nov-27-18 07:35AM  Research Report Identifies Cheniere Energy Partners, LP, Arena Pharmaceuticals, Geron, Keysight Technologies, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, and Casella Waste with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
05:00AM  Analysts: Why United Therapeutics has had a streak of licensing deals American City Business Journals
Nov-26-18 08:30AM  Arena Pharmaceuticals Expands Senior Management Team to Support Commercialization and Medical Affairs PR Newswire
Nov-23-18 12:58PM  2 New Small Cap ETFs on the Block Zacks
Nov-21-18 11:30AM  Opioid Alternatives Could Make Investors Major Gains ACCESSWIRE
11:21AM  Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal Zacks
Nov-20-18 08:30AM  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
Nov-17-18 03:53PM  Edited Transcript of ARNA earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
08:31AM  My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy Motley Fool
Nov-16-18 09:11AM  Arena (ARNA) Out-Licenses Rights to PAH Drug, Stock Up 22% Zacks +5.39%
07:00AM  Todays Research Reports on Stocks to Watch: Arena Pharmaceuticals and Sonoma Pharmaceuticals ACCESSWIRE
Nov-15-18 04:30PM  Why Arena Pharmaceuticals, Smart & Final Stores, and Tilray Jumped Today Motley Fool +21.62%
03:38PM  Stocks on the move: JP Morgan shares increase as Walmart beat estimates but shy on revenue Yahoo Finance Video
12:33PM  Why Arena Pharmaceuticals Stock Is Soaring Today InvestorPlace
11:05AM  Here's Why Arena Pharmaceuticals Jumped as Much as 30.6% Today Motley Fool
09:58AM  4 Stocks To Watch As Investors Dump Tech; Head To Healthcare ACCESSWIRE
07:33AM  United Therapeutics to develop, sell Arena Pharma's hypertension treatment Reuters
07:00AM  Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag PR Newswire
Nov-13-18 08:30AM  Arena Pharmaceuticals Presented Preclinical Data for APD418 in Development for Treatment of Decompensated Heart Failure at American Heart Association Scientific Sessions PR Newswire
Nov-09-18 10:22AM  Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales Zacks
Nov-07-18 04:01PM  Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results PR Newswire
02:58PM  Arena Pharmaceuticals: Don't Fight the Tape or Jim Cramer's Evaluation TheStreet.com
Oct-31-18 08:30AM  Arena Pharmaceuticals to Release Third Quarter 2018 Financial Results and Provide Corporate Update on November 7 PR Newswire
Oct-30-18 10:33AM  Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-15-18 09:20AM  Factors of Influence in 2018, Key Indicators and Opportunity within Meritor, Fred's, Arena Pharmaceuticals, AMERISAFE, Accelerate Diagnostics, and NextEra Energy New Research Emphasizes Economic Growth GlobeNewswire
Oct-09-18 07:56AM  Does Arena Pharmaceuticals Inc (NASDAQ:ARNA) Go Up With The Market? Simply Wall St.
Oct-08-18 04:01PM  Arena Pharmaceuticals Presented Phase 2 Clinical Data for Etrasimod in Ulcerative Colitis at the American College of Gastroenterology Annual Meeting PR Newswire
Oct-02-18 10:30AM  Global Stem Cell Market Expected to Reach $270.5 Billion ACCESSWIRE
08:00AM  Arena Pharmaceuticals Reports Positive Long-Term Data from the Ongoing Open-Label Extension of the Phase 2 Trial Evaluating Ralinepag for Treatment of Pulmonary Arterial Hypertension PR Newswire
Oct-01-18 08:00AM  Today's Research Reports on Trending Tickers: Momenta Pharmaceuticals and Arena Pharmaceuticals ACCESSWIRE
Sep-25-18 11:18AM  Arena (ARNA) Posts Favorable Top-Line Data on Pain Candidate Zacks
Sep-24-18 05:26PM  After-hours buzz: CTL, ARNA & more CNBC
04:01PM  Arena Pharmaceuticals Reports Positive Phase 2a Results for Olorinab in Patients with Abdominal Pain Associated with Crohn's Disease PR Newswire
Sep-21-18 09:15AM  Arena Pharmaceuticals to Host R&D Day on October 4 in New York City PR Newswire
Sep-20-18 08:30AM  Arena Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire
Sep-17-18 08:30AM  Arena Pharmaceuticals Presents Preclinical Data for Olorinab at International Association for the Study of Pain World Congress PR Newswire
08:00AM  Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and Emergent BioSolutions ACCESSWIRE
Sep-05-18 09:12AM  Why Is Arena Pharmaceuticals (ARNA) Up 7.4% Since Last Earnings Report? Zacks
Aug-29-18 04:30PM  Arena Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire
Aug-28-18 01:54PM  Arena Pharmaceuticals Presented Phase 1 Clinical Data for Ralinepag in Pulmonary Arterial Hypertension at the European Society of Cardiology PR Newswire
Aug-17-18 07:45PM  Edited Transcript of ARNA earnings conference call or presentation 6-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-14-18 08:25AM  New Research Coverage Highlights Arena Pharmaceuticals, Varian Medical, SS&C Technologies, Globus Medical, Zynga, and Diamondrock Hospitality Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Aug-07-18 10:52AM  Arena Pharmaceuticals (ARNA) Q2 Loss Wider Than Expected Zacks
Aug-06-18 04:01PM  Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2018 Financial Results PR Newswire
02:30PM  Arena Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
08:36AM  Arena Pharmaceuticals Q2 Earnings Outlook Benzinga
Jul-30-18 04:30PM  Arena Pharmaceuticals to Release Second Quarter 2018 Financial Results and Provide Corporate Update on Monday, August 6 PR Newswire
Jul-27-18 11:27AM  What's in the Cards for Arena (ARNA) This Earnings Season? Zacks
Jul-12-18 07:15AM  Free Pre-Market Technical Recap on ArQule and Three Additional Biotech ACCESSWIRE
Jul-10-18 08:30AM  Arena Pharmaceuticals Appoints Life Sciences Industry Veteran Kieran T. Gallahue to Board of Directors PR Newswire
Jul-02-18 08:20AM  Today's Research Reports on Trending Tickers: BioMarin Pharmaceutical and Arena Pharmaceuticals ACCESSWIRE
07:30AM  A Savvy Biotech Investor Is Betting Up To $25 Million Dollars On This $8 Stock Returning 250%... Or More? ACCESSWIRE
Jun-20-18 02:45PM  Is Arena Pharmaceuticals Inc (NASDAQ:ARNA) As Strong As Its Balance Sheet Indicates? Simply Wall St.
Jun-13-18 07:25AM  Initiating Free Research Reports on ArQule and Three Other Biotech Equities ACCESSWIRE
Jun-12-18 01:35PM  Will the Market Go Dead for a While? TheStreet.com
Jun-07-18 09:05AM  Arena Pharmaceuticals (ARNA) Up 15.1% Since Earnings Report: Can It Continue? Zacks
Jun-01-18 08:30AM  Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and Seattle Genetics ACCESSWIRE +5.16%
May-21-18 08:30AM  Arena Pharmaceuticals Announces Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference PR Newswire
May-17-18 11:17AM  Small-Caps Are the Place to Be for Now TheStreet.com
May-15-18 08:10AM  Report: Developing Opportunities within Haemonetics, Arena Pharmaceuticals, Xperi, MoneyGram International, Boot Barn, and Green Dot Future Expectations, Projections Moving into 2018 GlobeNewswire
May-11-18 12:25PM  Having Some Good Luck With Biotech Names TheStreet.com
May-10-18 08:30AM  Arena Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire
May-09-18 01:52PM  Markets Make an Art of Unpredictability TheStreet.com
01:46PM  Edited Transcript of ARNA earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
10:38AM  Arena Pharmaceuticals (ARNA) Q1 Loss Wider Than Expected Zacks
May-08-18 04:01PM  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2018 Financial Results PR Newswire
May-07-18 08:30AM  Drug/Biotech Q1 Earnings Lineup on May 8: JAZZ, ARNA & More Zacks
May-06-18 06:19PM  The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More Benzinga
May-03-18 08:30AM  Today's Research Reports on Trending Tickers: Insmed and Arena Pharmaceuticals ACCESSWIRE
May-02-18 08:30AM  Arena Pharmaceuticals to Release First Quarter 2018 Financial Results and Provide Corporate Update on Tuesday, May 8 PR Newswire +5.58%
May-01-18 11:08AM  What's in the Cards for Arena (ARNA) This Earnings Season? Zacks
08:30AM  Arena Pharmaceuticals and Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound PR Newswire
Apr-26-18 07:08PM  Cramer's lightning round: Now is the time to buy Walgreen... CNBC Videos
Apr-21-18 07:16AM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Apr-18-18 08:30AM  Todays Research Reports on Trending Tickers: GW Pharmaceuticals and Arena Pharmaceuticals ACCESSWIRE +5.73%
Apr-17-18 02:45PM  Arena CEO: We have two great assets and are trying to bui... CNBC Videos +7.96%
Apr-13-18 09:57AM  Arena Pharmaceuticals (ARNA) Up 7% Since Earnings Report: Can It Continue? Zacks
Apr-12-18 08:30AM  Arena Pharmaceuticals Announces Phase 2 Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the International Society for Heart and Lung Transplantation Annual Meeting PR Newswire
Apr-05-18 08:05AM  This $3 Medical Device Stock be Worth $9-14 with Impending Product Launch ACCESSWIRE
Mar-29-18 12:39PM  Arena Pharmaceuticals Inc (NASDAQ:ARNA): Earnings Growth Remains Elusive Simply Wall St.
Mar-26-18 04:15PM  Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares PR Newswire
11:00AM  This Obesity Drugmaker Just Made a Comeback While Another Declared Bankruptcy Motley Fool
Mar-24-18 09:32AM  3 Biotech Stocks That Skyrocketed This Week: Are They Buys? Motley Fool
Mar-23-18 07:30PM  Arena Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference on March 27 PR Newswire
06:00PM  Arena Pharmaceuticals Takes Aim at Celgene Motley Fool
Mar-22-18 04:58PM  One Biotech Turnaround to Watch Motley Fool -6.41%
08:41AM  Arena Pharmaceuticals (ARNA) in Focus: Stock Moves 10.7% Higher Zacks
Mar-21-18 07:07PM  Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire +10.69%
04:30PM  Why Whiting Petroleum, Arena Pharmaceuticals, and First Majestic Silver Jumped Today Motley Fool
03:24PM  Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday Motley Fool
10:39AM  Biotech Stock RoundUp: ALXN & ARNA Up on Study Data, PRTA Teams Up With Celgene Zacks
10:29AM  Company News For Mar 21, 2018 Zacks
08:10AM  Todays Research Reports on Trending Tickers: Arena Pharmaceuticals and CASI Pharmaceuticals ACCESSWIRE
Mar-20-18 05:08PM  What Happened in the Stock Market Today Motley Fool +28.68%
04:22PM  Arena Pharmaceuticals shares tick lower on secondary offering MarketWatch
04:16PM  Biotech Stock Jumps By A Third As Rivalry With Celgene Heats Investor's Business Daily
04:01PM  Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock PR Newswire
01:42PM  Why Arena Pharmaceuticals Shares Are Rocketing 31.6% Higher Today Motley Fool
11:43AM  Arena's (ARNA) Etrasimod Meets Phase II Colitis Study Goal Zacks
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for various therapeutic areas in the United States and Switzerland. Its proprietary investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod that is in Phase II trials for treating immune and inflammatory conditions with primary focus on ulcerative colitis and hepatic conditions, as well as for primary biliary cholangitis and pyoderma gangrenosum; and APD371, which is in Phase II trial for the treatment of pain associated with Crohn's disease. The company has collaboration agreements with Everest Medicines Limited; Axovant Sciences GmbH; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPECTOR STEVEN WEVP, General Counsel & SecAug 15Option Exercise18.1029,005524,99148,695Aug 17 05:17 PM
SPECTOR STEVEN WEVP, General Counsel & SecAug 15Sale36.0129,0051,044,50519,690Aug 17 05:17 PM
SPECTOR STEVEN WEVP, General Counsel & SecApr 16Option Exercise18.0030,001540,01849,691Apr 18 05:31 PM
SPECTOR STEVEN WEVP, General Counsel & SecApr 16Sale34.5730,0011,037,05819,690Apr 18 05:31 PM